Bovell table 1

Article

Table 1: Mean IOP over time.

Time

SLT

ALT

p-value

23.8±4.9 (89)

23.5±4.2 (87)

0.6014

17.9±4.8 (78)

17.8±3.9 (75)

0.8906

18.4±6.7 (79)

18.3±4.1 (71)

0.8921

17.0±6.0 (75)

17.6±4.1 (67)

0.4929

16.5±6.0 (72)

17.1±3.5 (62)

0.4371

15.9±5.2 (64)

16.9±5.8 (56)

0.2981

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Related Content
Placa Reial in Barcelona, Spain. A fountain is lit up by streetlamps. Tourists gather at night. Image credit: ©JackF – stock.adobe.com

24th EURETINA Congress: The art of retina on stage in Barcelona

Lynda Charters
September 10th 2024
Article

Focus on collaboration, career development and innovation

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A cell being injected by a syringe. Image credit: ©Corona Borealis – stock.adobe.com

Trinity team’s gene therapy offers promising glaucoma and AMD treatment

Martin David Harp
September 9th 2024
Article

Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A doctor uses the iCare ST500 with a patient. Image courtesy of iCare.

iCare debuts slit-lamp-mounted ST500 tonometer

Hattie Hayes
September 9th 2024
Article

The Finnish company shared technical specifications for the ST500

A woman driving at night touches her eye. Image credit: ©Drazen – stock.adobe.com

ESCRS 2024: A new EDOF IOL brings functional outcomes into the spotlight

Hattie Hayes
September 7th 2024
Article

Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile

© 2024 MJH Life Sciences

All rights reserved.